Cargando…
Drug dosing in hospitalized obese patients with COVID-19
Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for the pharmacokinetic alterations that exist in this populatio...
Autores principales: | Barletta, Jeffrey F., Erstad, Brian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919144/ https://www.ncbi.nlm.nih.gov/pubmed/35287690 http://dx.doi.org/10.1186/s13054-022-03941-1 |
Ejemplares similares
-
Drug dosing in the critically ill obese patient—a focus on sedation, analgesia, and delirium
por: Erstad, Brian L., et al.
Publicado: (2020) -
Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis
por: Erstad, Brian L., et al.
Publicado: (2021) -
Stress ulcer prophylaxis in trauma patients
por: Barletta, Jeffrey F, et al.
Publicado: (2002) -
It Takes a Village…: Contending With Drug Shortages During Disasters
por: Burry, Lisa D., et al.
Publicado: (2020) -
Survey of stress ulcer prophylaxis
por: Erstad, Brian L, et al.
Publicado: (1999)